ZygoFix Ltd, a portfolio firm of The Trendlines Group Ltd (Trendlines), has acquired regulatory approval from the US Food and Drug Administration for their zLOCK Lumbar Facet Fixation System. This success was reinforced by strong clinical evidence...
Gossamer Bio, Inc. (Gossamer), a clinical-stage biopharmaceutical organization centered on the progression and commercialization of seralutinib for the treatment of pulmonary hypertension, and Chiesi Farmaceutici S.p.A (Chiesi Gathering)...
Bristol Myers Squibb, a pharmaceutical firm, reported that the European Medicines Agency (EMA) has approved its Sort II variation application for Opdivo (nivolumab) in addition to Yervoy (ipilimumab) for the first-line therapy of grown-up patients...
Naprod Life Sciences (Naprod) announced today the successful renewal of its European Union Goods Manufacturing Practices (EU-GMP) certification for its manufacturing facility in Palghar.
Mediar Therapeutics, Inc., a biotechnology company developing a portfolio of first-in-class therapies to halt fibrosis progression, reported that the first cohort of participants in a phase 1 trial evaluating the safety and tolerability of MTX-463...
The Authentication Solution Providers' Association (ASPA), a proactive advocate in the fight against counterfeiting, spearheads a robust public awareness campaign, particularly within the pharmaceutical industry. Recognising the urgent need to add...
Emcure Pharmaceuticals, one of India’s leading pharmaceutical companies, unveiled its new corporate campaign with the tagline – ‘Cure and Beyond’, featuring cricketer MS Dhoni. In the ever-evolving world of healthcare, Emcure Pharmaceuticals...
RLAB Therapeutics, a pharmaceutical firm finding and creating novel therapies for Parkinson's ailments, reported that the Swedish Medical Products Agency has endorsed the commencement of stage I clinical investigation of the medication up-and...
Lupin Limited (Lupin) announced that the United States Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application for travoprost ophthalmic solution USP, 0.004% (ionic buffered solution), to market a generic equivalent...
Bespak, a main contract development and manufacturing organization (CDMO) focused on orally breathed-in and nasal drug-device gadget blend items, and H&T Presspart, a pharmaceutical firm, declared a coordinated effort to speed up the business...
, CDSCO.jpg)
.jpg)